How many studies have been conducted on Sizofiran?

BiohacksAI has indexed 50 PubMed studies on Sizofiran, including 8 randomized controlled trials (RCTs). 58% of studies involve human subjects.

What are the main research areas for Sizofiran?

The primary research domains for Sizofiran are 🔬 Oncology, 🔬 Inflammation, 🛡️ Immunity. This is based on analysis of 50 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Sizofiran

A beta-D-glucan obtained from the Aphyllophoral fungus Schizophyllum commune. It is used as an immunoadjuvant in the treatment of neoplasms, especially tumors found in the stomach.

50+ PubMed studies analyzed · 8 RCTs · Evidence Score: 48.1

Research Domains

Sizofiran has been studied across 9 research domains including 🔬 Oncology, 🔬 Inflammation, 🛡️ Immunity, 🧬 Hormones, 🫁 Liver & Detox. The primary research focus is 🔬 Oncology with 82% of studies addressing this area.

Loading evidence profile...

This evidence profile for Sizofiran is generated deterministically from 50 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.